Literature DB >> 19902052

Expression and activity of superoxide dismutase isoenzymes in colorectal cancer.

Michał Skrzycki1, Monika Majewska, Małgorzata Podsiad, Hanna Czeczot.   

Abstract

The aim of the study was an evaluation of changes in protein level and activity of SOD isoenzymes, and the participation of AP-1 and NF-kappaB in subsequent stages of colorectal cancer development. Studies were conducted on 65 colorectal cancers. Controls were unchanged colon regions. Activity of SOD isoenzymes, lipid peroxidation level (TBARS), and protein level of SOD1, SOD2, AP-1 and NF-kappaB were determined. We found that the protein level and activity of SOD isoenzymes and protein level of AP-1 and NF-kappaB change in subsequent stages of clinical advancement of colorectal cancer, according to UICC (I-IV), and in grades of tumor cells differentiation (G(1)-G(3)). These results indicate adaptation of colorectal cancer cells to oxidative stress, and show that the observed changes of SOD activity and protein level depend on gradual progression of colorectal cancer, and suggest an impairment of processes regulated by AP-1 and NF-kappaB which are critical for tumor progression (proliferation, differentiation and apoptosis).

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19902052

Source DB:  PubMed          Journal:  Acta Biochim Pol        ISSN: 0001-527X            Impact factor:   2.149


  9 in total

1.  Accumulation of the SET protein in HEK293T cells and mild oxidative stress: cell survival or death signaling.

Authors:  Andréia M Leopoldino; Cristiane H Squarize; Cristiana B Garcia; Luciana O Almeida; Cezar R Pestana; Ana C M Polizello; Sérgio A Uyemura; Eloiza H Tajara; J Silvio Gutkind; Carlos Curti
Journal:  Mol Cell Biochem       Date:  2011-12-06       Impact factor: 3.396

Review 2.  The intestinal microbiota, gastrointestinal environment and colorectal cancer: a putative role for probiotics in prevention of colorectal cancer?

Authors:  M Andrea Azcárate-Peril; Michael Sikes; José M Bruno-Bárcena
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2011-06-23       Impact factor: 4.052

3.  Activity of superoxide dismutase, catalase, glutathione peroxidase, and glutathione reductase in different stages of colorectal carcinoma.

Authors:  Kristina R Gopčević; Branislav R Rovčanin; Svetislav B Tatić; Zoran V Krivokapić; Milan M Gajić; Vesna V Dragutinović
Journal:  Dig Dis Sci       Date:  2013-04-27       Impact factor: 3.199

4.  Association of superoxide dismutase enzyme with staging and grade of differentiation colorectal cancer: A cross-sectional study.

Authors:  Budi Irawan; Ibrahim Labeda; Ronald Erasio Lusikooy; Samuel Sampetoding; M Ihwan Kusuma; Julianus Aboyaman Uwuratuw; Erwin Syarifuddin; Muhammad Faruk
Journal:  Ann Med Surg (Lond)       Date:  2020-09-02

5.  MAPRE1 as a plasma biomarker for early-stage colorectal cancer and adenomas.

Authors:  Ayumu Taguchi; Jung-Hyun Rho; Qingxiang Yan; Yuzheng Zhang; Yang Zhao; Hanwen Xu; Satyendra Chandra Tripathi; Hong Wang; Dean E Brenner; Melanie Kucherlapati; Raju Kucherlapati; Adam T Boutin; Y Alan Wang; Ronald A DePinho; Ziding Feng; Paul D Lampe; Samir M Hanash
Journal:  Cancer Prev Res (Phila)       Date:  2015-09-04

6.  Manganese-enhanced MRI for the detection of metastatic potential in colorectal cancer.

Authors:  Liang Wen; Xinan Shi; Liping He; Yi Lu; Dan Han
Journal:  Eur Radiol Exp       Date:  2017-11-02

7.  P2X7 siRNA targeted to the kidneys increases klotho and delays the progression of experimental diabetic nephropathy.

Authors:  A M Rodrigues; R S Serralha; D Y Lima; G R Punaro; I Visona; M J S Fernandes; E M S Higa
Journal:  Purinergic Signal       Date:  2020-05-06       Impact factor: 3.765

8.  Possibility of the use of public microarray database for identifying significant genes associated with oral squamous cell carcinoma.

Authors:  Ki-Yeol Kim; In-Ho Cha
Journal:  Genomics Inform       Date:  2012-03-31

9.  SOD3 and eNOS genotypes are associated with SOD activity and NOx.

Authors:  Xiaolong Dong; Dejun Li; Hong Liu; Yanyan Zhao
Journal:  Exp Ther Med       Date:  2014-05-19       Impact factor: 2.447

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.